USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Azilsartan
D08864 Azilsartan (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D08864 Azilsartan (JAN/USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
D08864 Azilsartan
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
D08864 Azilsartan
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D08864 Azilsartan
Drug classes [BR:br08332]
Cardiovascular agent
DG01495 Angiotensin II receptor antagonist
D08864 Azilsartan
DG03231 Antihypertensive
D08864 Azilsartan
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D08864 Azilsartan (JAN/USAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08864
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08864
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08864
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan